Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Direct-Skin Wearable Medical Devices Market by PRODUCT (GLUCOSE MONITORING PATCHES, HEART-MONITORING DEVICES, TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) ELECTRODES DEVICES, OTHERS) and by APPLICATION (METABOLIC DISORDERS, CARDIOVASCULAR DISORDERS, NEUROLOGICAL DISORDERS, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

A04481

Pages: NA

Charts: NA

Tables: NA

 Key Market Segments

  • By PRODUCT
    • GLUCOSE MONITORING PATCHES
    • HEART-MONITORING DEVICES
    • TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) ELECTRODES DEVICES
    • OTHERS
  • By APPLICATION
    • METABOLIC DISORDERS
    • CARDIOVASCULAR DISORDERS
    • NEUROLOGICAL DISORDERS
    • Others
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA

 
Key Market Players

  • Johnson & Johnson
  • Samsung
  • Intel
  • Smith & Nephew
  • Apple
  • Medtronic
  • Boston Scientific
  • Philips Healthcare
  • Google
  • Aventix

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. GLUCOSE MONITORING PATCHES

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. HEART-MONITORING DEVICES

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) ELECTRODES DEVICES

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. OTHERS

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

  • CHAPTER 5: DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. METABOLIC DISORDERS

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. CARDIOVASCULAR DISORDERS

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. NEUROLOGICAL DISORDERS

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Others

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

  • CHAPTER 6: DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Product

      • 6.2.3. Market Size and Forecast, By Application

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Direct-skin Wearable Medical Devices Market

        • 6.2.5.1. Market Size and Forecast, By Product
        • 6.2.5.2. Market Size and Forecast, By Application

      • 6.2.6. Canada Direct-skin Wearable Medical Devices Market

        • 6.2.6.1. Market Size and Forecast, By Product
        • 6.2.6.2. Market Size and Forecast, By Application

      • 6.2.7. Mexico Direct-skin Wearable Medical Devices Market

        • 6.2.7.1. Market Size and Forecast, By Product
        • 6.2.7.2. Market Size and Forecast, By Application

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Product

      • 6.3.3. Market Size and Forecast, By Application

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Direct-skin Wearable Medical Devices Market

        • 6.3.5.1. Market Size and Forecast, By Product
        • 6.3.5.2. Market Size and Forecast, By Application

      • 6.3.6. Germany Direct-skin Wearable Medical Devices Market

        • 6.3.6.1. Market Size and Forecast, By Product
        • 6.3.6.2. Market Size and Forecast, By Application

      • 6.3.7. Italy Direct-skin Wearable Medical Devices Market

        • 6.3.7.1. Market Size and Forecast, By Product
        • 6.3.7.2. Market Size and Forecast, By Application

      • 6.3.8. Spain Direct-skin Wearable Medical Devices Market

        • 6.3.8.1. Market Size and Forecast, By Product
        • 6.3.8.2. Market Size and Forecast, By Application

      • 6.3.9. UK Direct-skin Wearable Medical Devices Market

        • 6.3.9.1. Market Size and Forecast, By Product
        • 6.3.9.2. Market Size and Forecast, By Application

      • 6.3.10. Russia Direct-skin Wearable Medical Devices Market

        • 6.3.10.1. Market Size and Forecast, By Product
        • 6.3.10.2. Market Size and Forecast, By Application

      • 6.3.11. Rest Of Europe Direct-skin Wearable Medical Devices Market

        • 6.3.11.1. Market Size and Forecast, By Product
        • 6.3.11.2. Market Size and Forecast, By Application

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Product

      • 6.4.3. Market Size and Forecast, By Application

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Direct-skin Wearable Medical Devices Market

        • 6.4.5.1. Market Size and Forecast, By Product
        • 6.4.5.2. Market Size and Forecast, By Application

      • 6.4.6. Japan Direct-skin Wearable Medical Devices Market

        • 6.4.6.1. Market Size and Forecast, By Product
        • 6.4.6.2. Market Size and Forecast, By Application

      • 6.4.7. India Direct-skin Wearable Medical Devices Market

        • 6.4.7.1. Market Size and Forecast, By Product
        • 6.4.7.2. Market Size and Forecast, By Application

      • 6.4.8. South Korea Direct-skin Wearable Medical Devices Market

        • 6.4.8.1. Market Size and Forecast, By Product
        • 6.4.8.2. Market Size and Forecast, By Application

      • 6.4.9. Australia Direct-skin Wearable Medical Devices Market

        • 6.4.9.1. Market Size and Forecast, By Product
        • 6.4.9.2. Market Size and Forecast, By Application

      • 6.4.10. Thailand Direct-skin Wearable Medical Devices Market

        • 6.4.10.1. Market Size and Forecast, By Product
        • 6.4.10.2. Market Size and Forecast, By Application

      • 6.4.11. Malaysia Direct-skin Wearable Medical Devices Market

        • 6.4.11.1. Market Size and Forecast, By Product
        • 6.4.11.2. Market Size and Forecast, By Application

      • 6.4.12. Indonesia Direct-skin Wearable Medical Devices Market

        • 6.4.12.1. Market Size and Forecast, By Product
        • 6.4.12.2. Market Size and Forecast, By Application

      • 6.4.13. Rest of Asia Pacific Direct-skin Wearable Medical Devices Market

        • 6.4.13.1. Market Size and Forecast, By Product
        • 6.4.13.2. Market Size and Forecast, By Application

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Product

      • 6.5.3. Market Size and Forecast, By Application

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Direct-skin Wearable Medical Devices Market

        • 6.5.5.1. Market Size and Forecast, By Product
        • 6.5.5.2. Market Size and Forecast, By Application

      • 6.5.6. South Africa Direct-skin Wearable Medical Devices Market

        • 6.5.6.1. Market Size and Forecast, By Product
        • 6.5.6.2. Market Size and Forecast, By Application

      • 6.5.7. Saudi Arabia Direct-skin Wearable Medical Devices Market

        • 6.5.7.1. Market Size and Forecast, By Product
        • 6.5.7.2. Market Size and Forecast, By Application

      • 6.5.8. UAE Direct-skin Wearable Medical Devices Market

        • 6.5.8.1. Market Size and Forecast, By Product
        • 6.5.8.2. Market Size and Forecast, By Application

      • 6.5.9. Argentina Direct-skin Wearable Medical Devices Market

        • 6.5.9.1. Market Size and Forecast, By Product
        • 6.5.9.2. Market Size and Forecast, By Application

      • 6.5.10. Rest of LAMEA Direct-skin Wearable Medical Devices Market

        • 6.5.10.1. Market Size and Forecast, By Product
        • 6.5.10.2. Market Size and Forecast, By Application

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning, 2024

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. Philips Healthcare

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Medtronic

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Smith And Nephew

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. Boston Scientific

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. Johnson And Johnson

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Aventix

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Google

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Intel

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. Apple

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Samsung

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET FOR GLUCOSE MONITORING PATCHES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET FOR HEART-MONITORING DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) ELECTRODES DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET FOR METABOLIC DISORDERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET FOR CARDIOVASCULAR DISORDERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET FOR NEUROLOGICAL DISORDERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. NORTH AMERICA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. NORTH AMERICA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 14. NORTH AMERICA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 15. U.S. DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 16. U.S. DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 17. CANADA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 18. CANADA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 19. MEXICO DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 20. MEXICO DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 21. EUROPE DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 22. EUROPE DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 23. EUROPE DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 24. FRANCE DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 25. FRANCE DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 26. GERMANY DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 27. GERMANY DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 28. ITALY DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 29. ITALY DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 30. SPAIN DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 31. SPAIN DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 32. UK DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 33. UK DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 34. RUSSIA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 35. RUSSIA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 36. REST OF EUROPE DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 37. REST OF EUROPE DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 38. ASIA-PACIFIC DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 39. ASIA-PACIFIC DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 40. ASIA-PACIFIC DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 41. CHINA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 42. CHINA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 43. JAPAN DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 44. JAPAN DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 45. INDIA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 46. INDIA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 47. SOUTH KOREA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 48. SOUTH KOREA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 49. AUSTRALIA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 50. AUSTRALIA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 51. THAILAND DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 52. THAILAND DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 53. MALAYSIA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 54. MALAYSIA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 55. INDONESIA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 56. INDONESIA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 57. REST OF ASIA PACIFIC DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 58. REST OF ASIA PACIFIC DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 59. LAMEA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 60. LAMEA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 61. LAMEA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 62. BRAZIL DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 63. BRAZIL DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 64. SOUTH AFRICA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 65. SOUTH AFRICA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 66. SAUDI ARABIA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 67. SAUDI ARABIA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 68. UAE DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 69. UAE DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 70. ARGENTINA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 71. ARGENTINA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 72. REST OF LAMEA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 73. REST OF LAMEA DIRECT-SKIN WEARABLE MEDICAL DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 74. PHILIPS HEALTHCARE: KEY EXECUTIVES
  • TABLE 75. PHILIPS HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 76. PHILIPS HEALTHCARE: OPERATING SEGMENTS
  • TABLE 77. PHILIPS HEALTHCARE: PRODUCT PORTFOLIO
  • TABLE 78. PHILIPS HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 79. MEDTRONIC: KEY EXECUTIVES
  • TABLE 80. MEDTRONIC: COMPANY SNAPSHOT
  • TABLE 81. MEDTRONIC: OPERATING SEGMENTS
  • TABLE 82. MEDTRONIC: PRODUCT PORTFOLIO
  • TABLE 83. MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 84. SMITH AND NEPHEW: KEY EXECUTIVES
  • TABLE 85. SMITH AND NEPHEW: COMPANY SNAPSHOT
  • TABLE 86. SMITH AND NEPHEW: OPERATING SEGMENTS
  • TABLE 87. SMITH AND NEPHEW: PRODUCT PORTFOLIO
  • TABLE 88. SMITH AND NEPHEW: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 89. BOSTON SCIENTIFIC: KEY EXECUTIVES
  • TABLE 90. BOSTON SCIENTIFIC: COMPANY SNAPSHOT
  • TABLE 91. BOSTON SCIENTIFIC: OPERATING SEGMENTS
  • TABLE 92. BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
  • TABLE 93. BOSTON SCIENTIFIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 94. JOHNSON AND JOHNSON: KEY EXECUTIVES
  • TABLE 95. JOHNSON AND JOHNSON: COMPANY SNAPSHOT
  • TABLE 96. JOHNSON AND JOHNSON: OPERATING SEGMENTS
  • TABLE 97. JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
  • TABLE 98. JOHNSON AND JOHNSON: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 99. AVENTIX: KEY EXECUTIVES
  • TABLE 100. AVENTIX: COMPANY SNAPSHOT
  • TABLE 101. AVENTIX: OPERATING SEGMENTS
  • TABLE 102. AVENTIX: PRODUCT PORTFOLIO
  • TABLE 103. AVENTIX: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 104. GOOGLE: KEY EXECUTIVES
  • TABLE 105. GOOGLE: COMPANY SNAPSHOT
  • TABLE 106. GOOGLE: OPERATING SEGMENTS
  • TABLE 107. GOOGLE: PRODUCT PORTFOLIO
  • TABLE 108. GOOGLE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 109. INTEL: KEY EXECUTIVES
  • TABLE 110. INTEL: COMPANY SNAPSHOT
  • TABLE 111. INTEL: OPERATING SEGMENTS
  • TABLE 112. INTEL: PRODUCT PORTFOLIO
  • TABLE 113. INTEL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 114. APPLE: KEY EXECUTIVES
  • TABLE 115. APPLE: COMPANY SNAPSHOT
  • TABLE 116. APPLE: OPERATING SEGMENTS
  • TABLE 117. APPLE: PRODUCT PORTFOLIO
  • TABLE 118. APPLE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 119. SAMSUNG: KEY EXECUTIVES
  • TABLE 120. SAMSUNG: COMPANY SNAPSHOT
  • TABLE 121. SAMSUNG: OPERATING SEGMENTS
  • TABLE 122. SAMSUNG: PRODUCT PORTFOLIO
  • TABLE 123. SAMSUNG: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET SEGMENTATION
  • FIGURE 2. GLOBAL DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET
  • FIGURE 3. SEGMENTATION DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALDIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET
  • FIGURE 11. DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 12. DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET FOR GLUCOSE MONITORING PATCHES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET FOR HEART-MONITORING DEVICES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) ELECTRODES DEVICES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 17. DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET FOR METABOLIC DISORDERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET FOR CARDIOVASCULAR DISORDERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET FOR NEUROLOGICAL DISORDERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 22. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 23. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 24. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 25. COMPETITIVE DASHBOARD
  • FIGURE 26. COMPETITIVE HEATMAP: DIRECT-SKIN WEARABLE MEDICAL DEVICES MARKET
  • FIGURE 27. TOP PLAYER POSITIONING, 2024
  • FIGURE 28. PHILIPS HEALTHCARE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 29. PHILIPS HEALTHCARE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 30. PHILIPS HEALTHCARE: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 31. MEDTRONIC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 32. MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 33. MEDTRONIC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 34. SMITH AND NEPHEW: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 35. SMITH AND NEPHEW: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 36. SMITH AND NEPHEW: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 37. BOSTON SCIENTIFIC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 38. BOSTON SCIENTIFIC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 39. BOSTON SCIENTIFIC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 40. JOHNSON AND JOHNSON: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 41. JOHNSON AND JOHNSON: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 42. JOHNSON AND JOHNSON: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 43. AVENTIX: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 44. AVENTIX: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 45. AVENTIX: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 46. GOOGLE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 47. GOOGLE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 48. GOOGLE: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 49. INTEL: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 50. INTEL: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 51. INTEL: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 52. APPLE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 53. APPLE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 54. APPLE: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 55. SAMSUNG: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 56. SAMSUNG: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 57. SAMSUNG: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Direct-Skin Wearable Medical Devices Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved